In the aftermath of the recent US Supreme Court decision on gene patents, what is the likely effect on the UK biotech startup sector and life sciences in general? This question was put to me in so many ways following
The economic slump is not going away. The Coalition government likes to say that the glue holding it together is its commitment to eliminating the structural public deficit over four years. But its confidence that deficit reduction alone boosts private
Innovation – who can argue with that? If it promises to make our world a better place, it would rightly get a full show of hands. But patents, drafting patents, filing patents and prosecuting patents – what’s exciting about that?